• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FKBP的溶液结构,一种肽基脯氨酰顺反异构酶以及FK506和雷帕霉素的受体。

Solution structure of FKBP, a rotamase enzyme and receptor for FK506 and rapamycin.

作者信息

Michnick S W, Rosen M K, Wandless T J, Karplus M, Schreiber S L

机构信息

Department of Chemistry, Harvard University, Cambridge, MA 02138.

出版信息

Science. 1991 May 10;252(5007):836-9. doi: 10.1126/science.1709301.

DOI:10.1126/science.1709301
PMID:1709301
Abstract

Immunophilins, when complexed to immunosuppressive ligands, appear to inhibit signal transduction pathways that result in exocytosis and transcription. The solution structure of one of these, the human FK506 and rapamycin binding protein (FKBP), has been determined by nuclear magnetic resonance (NMR). FKBP has a previously unobserved antiparallel beta-sheet folding topology that results in a novel loop crossing and produces a large cavity lined by a conserved array of aromatic residues; this cavity serves as the rotamase active site and drug-binding pocket. There are other significant structural features (such as a protruding positively charged loop and an apparently flexible loop) that may be involved in the biological activity of FKBP.

摘要

免疫亲和素与免疫抑制配体结合时,似乎会抑制导致胞吐作用和转录的信号转导途径。其中之一,即人FK506和雷帕霉素结合蛋白(FKBP)的溶液结构已通过核磁共振(NMR)确定。FKBP具有一种以前未观察到的反平行β-折叠拓扑结构,这种结构导致了一种新的环交叉,并产生了一个由保守的芳香族残基阵列排列而成的大腔;这个腔作为肽基脯氨酰顺反异构酶活性位点和药物结合口袋。还有其他重要的结构特征(如一个突出的带正电荷的环和一个明显灵活的环)可能参与FKBP的生物活性。

相似文献

1
Solution structure of FKBP, a rotamase enzyme and receptor for FK506 and rapamycin.FKBP的溶液结构,一种肽基脯氨酰顺反异构酶以及FK506和雷帕霉素的受体。
Science. 1991 May 10;252(5007):836-9. doi: 10.1126/science.1709301.
2
Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex.
Science. 1991 May 10;252(5007):839-42. doi: 10.1126/science.1709302.
3
Molecular cloning of a membrane-associated human FK506- and rapamycin-binding protein, FKBP-13.一种膜相关的人类FK506和雷帕霉素结合蛋白FKBP - 13的分子克隆
Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6677-81. doi: 10.1073/pnas.88.15.6677.
4
Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast.免疫抑制剂雷帕霉素在酵母中引起细胞周期停滞的靶点。
Science. 1991 Aug 23;253(5022):905-9. doi: 10.1126/science.1715094.
5
Exon organization of the human FKBP-12 gene: correlation with structural and functional protein domains.人类FKBP - 12基因的外显子组织:与蛋白质结构和功能域的相关性
Biochemistry. 1991 Sep 3;30(35):8512-7. doi: 10.1021/bi00099a002.
6
Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin.人亲免素FKBP-12与FK506及雷帕霉素复合物的原子结构。
J Mol Biol. 1993 Jan 5;229(1):105-24. doi: 10.1006/jmbi.1993.1012.
7
Probing immunosuppressant action with a nonnatural immunophilin ligand.用非天然亲免素配体探究免疫抑制剂作用
Science. 1990 Oct 26;250(4980):556-9. doi: 10.1126/science.1700475.
8
Probing hydration contributions to the thermodynamics of ligand binding by proteins. Enthalpy and heat capacity changes of tacrolimus and rapamycin binding to FK506 binding protein in D2O and H2O.探究水合作用对蛋白质配体结合热力学的贡献。他克莫司和雷帕霉素在重水和水中与FK506结合蛋白结合时的焓变和热容变化。
Biochemistry. 1993 Jun 1;32(21):5583-90. doi: 10.1021/bi00072a013.
9
Solution structure of the major binding protein for the immunosuppressant FK506.免疫抑制剂FK506主要结合蛋白的溶液结构
Nature. 1991 May 16;351(6323):248-50. doi: 10.1038/351248a0.
10
Proton and nitrogen sequential assignments and secondary structure determination of the human FK506 and rapamycin binding protein.
Biochemistry. 1991 May 14;30(19):4774-89. doi: 10.1021/bi00233a020.

引用本文的文献

1
Mimicry of molecular glues using dual covalent chimeras.使用双共价嵌合体模拟分子胶水。
Nat Commun. 2025 Mar 24;16(1):2855. doi: 10.1038/s41467-025-58083-z.
2
Regulating ferredoxin electron transfer using nanobody and antigen interactions.利用纳米抗体与抗原的相互作用调控铁氧化还原蛋白的电子转移
RSC Chem Biol. 2025 Jan 31;6(5):746-753. doi: 10.1039/d4cb00257a. eCollection 2025 May 8.
3
The TOR signalling pathway in fungal phytopathogens: A target for plant disease control.真菌植物病原菌中的 TOR 信号通路:植物疾病防治的一个靶点。
Mol Plant Pathol. 2024 Nov;25(11):e70024. doi: 10.1111/mpp.70024.
4
Insights into Peptidyl-Prolyl - Isomerases from Clinically Important Protozoans: From Structure to Potential Biotechnological Applications.对来自临床重要原生动物的肽基脯氨酰异构酶的见解:从结构到潜在的生物技术应用
Pathogens. 2024 Jul 31;13(8):644. doi: 10.3390/pathogens13080644.
5
EGFR targeting PhosTACs as a dual inhibitory approach reveals differential downstream signaling.EGFR 靶向 PhosTACs 作为一种双重抑制方法揭示了差异化的下游信号转导。
Sci Adv. 2024 Mar 29;10(13):eadj7251. doi: 10.1126/sciadv.adj7251. Epub 2024 Mar 27.
6
Synthetic Biology Meets Ca Release-Activated Ca Channel-Dependent Immunomodulation.合成生物学与钙释放激活钙通道依赖的免疫调节相遇。
Cells. 2024 Mar 7;13(6):468. doi: 10.3390/cells13060468.
7
Small molecules targeting Pin1 as potent anticancer drugs.靶向Pin1的小分子作为强效抗癌药物。
Front Pharmacol. 2023 Mar 27;14:1073037. doi: 10.3389/fphar.2023.1073037. eCollection 2023.
8
Leveraging Fungal and Human Calcineurin-Inhibitor Structures, Biophysical Data, and Dynamics To Design Selective and Nonimmunosuppressive FK506 Analogs.利用真菌和人类钙调磷酸酶抑制剂结构、生物物理数据和动力学设计选择性和非免疫抑制性 FK506 类似物。
mBio. 2021 Dec 21;12(6):e0300021. doi: 10.1128/mBio.03000-21. Epub 2021 Nov 23.
9
Targeted Covalent Inhibition of FK506 Binding Protein 35.FK506结合蛋白35的靶向共价抑制
ACS Med Chem Lett. 2020 Sep 1;11(11):2131-2138. doi: 10.1021/acsmedchemlett.0c00272. eCollection 2020 Nov 12.
10
Fpr1, a primary target of rapamycin, functions as a transcription factor for ribosomal protein genes cooperatively with Hmo1 in Saccharomyces cerevisiae.雷帕霉素的主要靶点 Fpr1 在酿酒酵母中与 Hmo1 协同作用,作为核糖体蛋白基因的转录因子。
PLoS Genet. 2020 Jun 30;16(6):e1008865. doi: 10.1371/journal.pgen.1008865. eCollection 2020 Jun.